{
  "DOI": "10.1038/s41431-021-01011-8",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-021-01011-8",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eIt is 30 years since the first diagnostic cancer predisposition gene (CPG) test in the Manchester Centre for Genomic Medicine (MCGM), providing opportunities for cancer prevention, early detection and targeted treatments in index cases and at-risk family members. Here, we present time trends (1990–2020) of identification of index cases with a germline CPG variant and numbers of subsequent cascade tests, for 15 high-risk breast and gastro-intestinal tract cancer-associated CPGs: \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e, \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e, \u003cjats:italic\u003ePALB2\u003c/jats:italic\u003e, \u003cjats:italic\u003ePTEN\u003c/jats:italic\u003e, \u003cjats:italic\u003eTP53\u003c/jats:italic\u003e, \u003cjats:italic\u003eAPC\u003c/jats:italic\u003e, \u003cjats:italic\u003eBMPR1a\u003c/jats:italic\u003e, \u003cjats:italic\u003eCDH1\u003c/jats:italic\u003e, \u003cjats:italic\u003eMLH1\u003c/jats:italic\u003e, \u003cjats:italic\u003eMSH2\u003c/jats:italic\u003e, \u003cjats:italic\u003eMSH6\u003c/jats:italic\u003e, \u003cjats:italic\u003ePMS2\u003c/jats:italic\u003e, \u003cjats:italic\u003eSMAD4\u003c/jats:italic\u003e, \u003cjats:italic\u003eSTK11\u003c/jats:italic\u003e and \u003cjats:italic\u003eMUTYH\u003c/jats:italic\u003e. We recorded 2082 positive index case diagnostic screening tests, generating 3216 positive and 3140 negative family cascade (non-index) tests. This is equivalent to an average of 3.05 subsequent cascade tests per positive diagnostic index test, with 1.54 positive and 1.51 negative non-index tests per family. The CPGs with the highest numbers of non-index positive cases identified on cascade testing were \u003cjats:italic\u003eBRCA1/2\u003c/jats:italic\u003e (\u003cjats:italic\u003en\u003c/jats:italic\u003e = 1999) and the mismatch repair CPGs associated with Lynch Syndrome (\u003cjats:italic\u003en\u003c/jats:italic\u003e = 731). These data are important for service provision and health economic assessment of CPG diagnostic testing, in terms of cancer prevention and early detection strategies, and identifying those likely to benefit from targeted treatment strategies.\u003c/jats:p\u003e",
  "alternative-id": [
    "1011"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "15 February 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "27 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "15 November 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "6 December 2021"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "D.G.E. has undertaken consultancy work for Astrazeneca and Springworks."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "No specific ethical approval was required for this study. All genetic testing results referred to in this study were from patients who had given consent to genetic testing."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-6297-2855",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Woodward",
      "given": "Emma R.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Green",
      "given": "Kate",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Burghel",
      "given": "George J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bulman",
      "given": "Michael",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Clancy",
      "given": "Tara",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lalloo",
      "given": "Fiona",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schlecht",
      "given": "Helene",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wallace",
      "given": "Andrew J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-8482-5784",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Evans",
      "given": "D. Gareth",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        12,
        6
      ]
    ],
    "date-time": "2021-12-06T01:02:37Z",
    "timestamp": 1638752557000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        4,
        7
      ]
    ],
    "date-time": "2022-04-07T23:10:38Z",
    "timestamp": 1649373038000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        19
      ]
    ],
    "date-time": "2024-04-19T16:09:36Z",
    "timestamp": 1713542976677
  },
  "is-referenced-by-count": 19,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2021,
        12,
        6
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2022,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            12,
            6
          ]
        ],
        "date-time": "2021-12-06T00:00:00Z",
        "timestamp": 1638748800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            12,
            6
          ]
        ],
        "date-time": "2021-12-06T00:00:00Z",
        "timestamp": 1638748800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-021-01011-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-01011-8",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-01011-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "413-419",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2021,
        12,
        6
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        12,
        6
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1136/jmg.33.2.120",
      "author": "IR Maddock",
      "doi-asserted-by": "publisher",
      "first-page": "120",
      "journal-title": "J Med Genet",
      "key": "1011_CR1",
      "unstructured": "Maddock IR, Moran A, Maher ER, Teare MD, Norman A, Payne SJ, et al. A genetic register for von Hippel-Lindau disease. J Med Genet. 1996;33:120–7.",
      "volume": "33",
      "year": "1996"
    },
    {
      "DOI": "10.1136/jmg.34.9.746",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "746",
      "journal-title": "J Med Genet",
      "key": "1011_CR2",
      "unstructured": "Evans DG, Maher ER, Macleod R, Davies DR, Craufurd D. Uptake of genetic testing for cancer predisposition. J Med Genet. 1997;34:746–8.",
      "volume": "34",
      "year": "1997"
    },
    {
      "DOI": "10.1054/bjoc.2001.1893",
      "author": "D Wonderling",
      "doi-asserted-by": "publisher",
      "first-page": "166",
      "journal-title": "Br J Cancer",
      "key": "1011_CR3",
      "unstructured": "Wonderling D, Hopwood P, Cull A, Douglas F, Watson M, Burn J, et al. A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics. Br J Cancer. 2001;85:166–70.",
      "volume": "85",
      "year": "2001"
    },
    {
      "DOI": "10.1002/humu.20880",
      "author": "SE Plon",
      "doi-asserted-by": "publisher",
      "first-page": "1282",
      "journal-title": "Hum Mutat",
      "key": "1011_CR4",
      "unstructured": "Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, et al. IARC Unclassified Genetic Variants Working Group. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008;29:1282–91.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "1011_CR5",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–23.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.1978757",
      "author": "D Malkin",
      "doi-asserted-by": "publisher",
      "first-page": "1233",
      "journal-title": "Science",
      "key": "1011_CR6",
      "unstructured": "Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233–8.",
      "volume": "250",
      "year": "1990"
    },
    {
      "DOI": "10.1038/ng1959",
      "author": "N Rahman",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "journal-title": "Nat Genet",
      "key": "1011_CR7",
      "unstructured": "Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007;39:165–7.",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMoa1400382",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "journal-title": "N Engl J Med",
      "key": "1011_CR8",
      "unstructured": "Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkäs K, Roberts J, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371:497–506.",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.19.01907",
      "doi-asserted-by": "crossref",
      "key": "1011_CR9",
      "unstructured": "Yang X, Leslie G, Doroszuk A, Aittomäki K, Blomqvist C, Heikkinen T et al. Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol. 2020;38:674–85."
    },
    {
      "DOI": "10.1158/2159-8290.CD-17-1415",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "803",
      "journal-title": "Cancer Discov",
      "key": "1011_CR10",
      "unstructured": "Rebbeck TR, Burns-White K, Chan AT, Emmons K, Freedman M, Hunter DJ, et al. Precision prevention and early detection of cancer: fundamental principles. Cancer Discov. 2018;8:803–11.",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2014.56.2728",
      "author": "B Kaufman",
      "doi-asserted-by": "publisher",
      "first-page": "244",
      "journal-title": "J Clin Oncol",
      "key": "1011_CR11",
      "unstructured": "Kaufman B, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmaña J, et al. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J Clin Oncol. 2015;33:244–50.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa1500596",
      "author": "DT Le",
      "doi-asserted-by": "publisher",
      "first-page": "2509",
      "journal-title": "N Engl J Med",
      "key": "1011_CR12",
      "unstructured": "Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372:2509–20.",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1007/BF02053699",
      "author": "HF Vasen",
      "doi-asserted-by": "publisher",
      "first-page": "424",
      "journal-title": "Dis Colon Rectum",
      "key": "1011_CR13",
      "unstructured": "Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424–5.",
      "volume": "34",
      "year": "1991"
    },
    {
      "DOI": "10.1016/S0016-5085(99)70510-X",
      "author": "HF Vasen",
      "doi-asserted-by": "publisher",
      "first-page": "1453",
      "journal-title": "Gastroenterology",
      "key": "1011_CR14",
      "unstructured": "Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453–6.",
      "volume": "116",
      "year": "1999"
    },
    {
      "author": "HM van der Klift",
      "first-page": "578",
      "journal-title": "Hum Mutat",
      "key": "1011_CR15",
      "unstructured": "van der Klift HM, Tops CM, Bik EC, Boogaard MW, Borgstein AM, Hansson KB, et al. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients. Hum Mutat. 2010;31:578–87.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.jmoldx.2015.04.001",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "545",
      "journal-title": "J Mol Diagn",
      "key": "1011_CR16",
      "unstructured": "Li J, Dai H, Feng Y, Tang J, Chen S, Tian X, et al. A comprehensive strategy for accurate mutation detection of the highly homologous PMS2. J Mol Diagn. 2015;17:545–53.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41436-019-0596-9",
      "author": "M Dominguez-Valentin",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Genet Med",
      "key": "1011_CR17",
      "unstructured": "Dominguez-Valentin M, Sampson JR, Seppälä TT, Sanne W, Plazzer JP, Nakken S, et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020;22:15–25.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41591-020-0982-5",
      "author": "JJ Grzymski",
      "doi-asserted-by": "publisher",
      "first-page": "1235",
      "journal-title": "Nat Med",
      "key": "1011_CR18",
      "unstructured": "Grzymski JJ, Elhanan G, Rosado JM, Smith E, Schlauch KA, Read R, et al. Population genetic screening efficiently identifies carriers of autosomal dominant diseases. Nat Med. 2020;26:1235–9.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1136/jmedgenet-2014-102284",
      "author": "K Wimmer",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "journal-title": "J Med Genet",
      "key": "1011_CR19",
      "unstructured": "Wimmer K, Kratz CP, Vasen HF, Caron O, Colas C, Entz-Werle N, et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’(C4CMMRD). J Med Genet. 2014;51:355–65.",
      "volume": "51",
      "year": "2014"
    },
    {
      "DOI": "10.1136/jmg.2003.017996",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "474",
      "journal-title": "J Med Genet",
      "key": "1011_CR20",
      "unstructured": "Evans DG, Eccles DM, Rahman N, Young K, Bulman M, Amir E, et al. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet. 2004;41:474–80.",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmedgenet-2017-104584",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "674",
      "journal-title": "J Med Genet",
      "key": "1011_CR21",
      "unstructured": "Evans DG, Harkness EF, Plaskocinska I, Wallace AJ, Clancy T, Woodward ER, et al. Pathology update to the Manchester Scoring System based on testing in over 4000 families. J Med Genet. 2017;54:674–81.",
      "volume": "54",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41431-020-0692-y",
      "author": "N Flaum",
      "doi-asserted-by": "publisher",
      "first-page": "1541",
      "journal-title": "Eur J Hum Genet",
      "key": "1011_CR22",
      "unstructured": "Flaum N, Morgan RD, Burghel GJ, Bulman M, Clamp AR, Hasan J, et al. Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England. Eur J Hum Genet. 2020;28:1541–7.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1056/NEJMoa1913948",
      "author": "L Dorling",
      "doi-asserted-by": "publisher",
      "first-page": "428",
      "journal-title": "N Engl J Med",
      "key": "1011_CR23",
      "unstructured": "Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, et al. Breast cancer risk genes: association analysis in more than 113,000 women. N Engl J Med. 2021;384:428–39.",
      "volume": "384",
      "year": "2021"
    },
    {
      "DOI": "10.1056/NEJMra1001389",
      "author": "WD Foulkes",
      "doi-asserted-by": "publisher",
      "first-page": "1938",
      "journal-title": "N Engl J Med",
      "key": "1011_CR24",
      "unstructured": "Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48.",
      "volume": "363",
      "year": "2010"
    },
    {
      "DOI": "10.1136/jmedgenet-2018-105792",
      "author": "RD Morgan",
      "doi-asserted-by": "publisher",
      "first-page": "301",
      "journal-title": "J Med Genet",
      "key": "1011_CR25",
      "unstructured": "Morgan RD, Burghel GJ, Flaum N, Bulman M, Clamp AR, Hasan J, et al. Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases. J Med Genet. 2019;56:301–7.",
      "volume": "56",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10689-013-9611-5",
      "author": "H Hampel",
      "doi-asserted-by": "publisher",
      "first-page": "313",
      "journal-title": "Fam Cancer",
      "key": "1011_CR26",
      "unstructured": "Hampel H, de la Chapelle A. How do we approach the goal of identifying everybody with Lynch Syndrome? Fam Cancer. 2013;12:313–7.",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1002/humu.22938",
      "author": "MJ Smith",
      "doi-asserted-by": "publisher",
      "first-page": "250",
      "journal-title": "Hum Mutat",
      "key": "1011_CR27",
      "unstructured": "Smith MJ, Urquhart JE, Harkness EF, Miles EK, Bowers NL, Byers HJ, et al. The contribution of whole gene deletions and large rearrangements to the mutation spectrum in inherited tumor predisposing syndromes. Hum Mutat. 2016;373:250–6.",
      "volume": "373",
      "year": "2016"
    },
    {
      "DOI": "10.1126/science.1117389",
      "author": "J Shendure",
      "doi-asserted-by": "publisher",
      "first-page": "1728",
      "journal-title": "Science",
      "key": "1011_CR28",
      "unstructured": "Shendure J, Porreca GJ, Reppas NB, Lin X, McCutcheon JP, et al. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 2005;309:1728–32.",
      "volume": "309",
      "year": "2005"
    },
    {
      "DOI": "10.1038/s41431-020-0618-8",
      "author": "FH Menko",
      "doi-asserted-by": "publisher",
      "first-page": "1020",
      "journal-title": "Eur J Hum Genet",
      "key": "1011_CR29",
      "unstructured": "Menko FH, Jeanson KN, Bleiker EM, van Tiggelen CW, Hogervorst FB, ter Stege JA, et al. The uptake of predictive DNA testing in 40 families with a pathogenic BRCA1/BRCA2 variant. An evaluation of the proband-mediated procedure. Eur J Hum Genet. 2020;28:1020–7.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.ajhg.2018.07.002",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "213",
      "journal-title": "Am J Hum Genet",
      "key": "1011_CR30",
      "unstructured": "Evans DG, van Veen EM, Byers HJ, Wallace AJ, Ellingford JM, Beaman G, et al. A dominantly inherited 5′ UTR variant causing methylation-associated silencing of BRCA1 as a cause of breast and ovarian cancer. Am J Hum Genet. 2018;103:213–20.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1136/jmedgenet-2020-107087",
      "doi-asserted-by": "crossref",
      "key": "1011_CR31",
      "unstructured": "Hyder Z, Fairclough A, Groom M, Getty J, Alexander E, van Veen EM et al. Constitutional de novo deletion CNV encompassing REST predisposes to diffuse hyperplastic perilobar nephroblastomatosis (HPLN). J Med Genet. 2020;58:581–5."
    },
    {
      "DOI": "10.1038/s41436-020-0880-8",
      "author": "ML Thibodeau",
      "doi-asserted-by": "publisher",
      "first-page": "1892",
      "journal-title": "Genet Med",
      "key": "1011_CR32",
      "unstructured": "Thibodeau ML, O’Neill K, Dixon K, Reisle C, Mungall KL, Krzywinski M, et al. Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing. Genet Med. 2020;22:1892–7.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1136/jmedgenet-2019-106759",
      "author": "A Garrett",
      "doi-asserted-by": "publisher",
      "first-page": "829",
      "journal-title": "J Med Genet",
      "key": "1011_CR33",
      "unstructured": "Garrett A, Callaway A, Durkie M, Cubuk C, Alikian M, Burghel GJ, et al. Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network. J Med Genet. 2020;57:829–34.",
      "volume": "57",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s10689-020-00207-z",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Fam Cancer",
      "key": "1011_CR34",
      "unstructured": "Evans DG, Woodward ER. New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer. Fam Cancer. 2021;20:1–7.",
      "volume": "20",
      "year": "2021"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-021-01011-8"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}